What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Nelson Leung spends much of his time researching Internal medicine, Multiple myeloma, Gastroenterology, Pathology and Amyloidosis.
His research integrates issues of Endocrinology and Surgery in his study of Internal medicine.
Nelson Leung has researched Multiple myeloma in several fields, including Disease, Chemotherapy and Oncology.
His studies in Gastroenterology integrate themes in fields like Survival analysis, Membranous nephropathy, Hematologic Response and Rituximab.
Nelson Leung interconnects Monoclonal gammopathy of undetermined significance and Kidney, Glomerulonephritis in the investigation of issues within Pathology.
His Amyloidosis research integrates issues from Immunoglobulin Light-chain Amyloidosis, AL amyloidosis, Renal amyloidosis and Amyloid.
His most cited work include:
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients (768 citations)
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements (508 citations)
- Monoclonal Gammopathy of Renal Significance: When MGUS Is No Longer Undetermined or Insignificant (324 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Gastroenterology, Pathology and Amyloidosis.
His Internal medicine research is multidisciplinary, incorporating elements of Surgery and Oncology.
His studies deal with areas such as Newly diagnosed and Bone marrow as well as Multiple myeloma.
His Gastroenterology course of study focuses on Renal function and Urology.
In his work, Kidney disease and Monoclonal is strongly intertwined with Kidney, which is a subfield of Pathology.
His work carried out in the field of Amyloidosis brings together such families of science as Immunoglobulin light chain, Hematologic Response, Immunoglobulin Light-chain Amyloidosis and Amyloid.
He most often published in these fields:
- Internal medicine (60.17%)
- Multiple myeloma (35.64%)
- Gastroenterology (26.41%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (60.17%)
- Multiple myeloma (35.64%)
- Amyloidosis (22.51%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Multiple myeloma, Amyloidosis, Gastroenterology and AL amyloidosis.
The Internal medicine study which covers Oncology that intersects with Disease.
The study incorporates disciplines such as Bone marrow and Urology in addition to Multiple myeloma.
His study on Amyloidosis also encompasses disciplines like
- Immunoglobulin light chain together with Pathology, Isotype and Immunoglobulin heavy chain,
- Transplantation which is related to area like Thrombotic microangiopathy.
His Gastroenterology research is multidisciplinary, relying on both Survival rate, Lymphoma, Acute kidney injury and Renal function.
His biological study deals with issues like Kidney transplantation, which deal with fields such as Immunoglobulin Light-chain Amyloidosis.
Between 2019 and 2021, his most popular works were:
- Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis. (20 citations)
- Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes. (14 citations)
- Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis. (13 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Amyloidosis, Multiple myeloma, Pathology and Gastroenterology are his primary areas of study.
The Amyloidosis study combines topics in areas such as Hematologic Response, Immunoglobulin light chain, AL amyloidosis, Amyloid and Very Good Partial Response.
His biological study spans a wide range of topics, including Dialysis, Anemia and Monoclonal protein.
His work deals with themes such as Immunofluorescence, Glomerulonephritis and Flow cytometry, which intersect with Pathology.
His Gastroenterology study integrates concerns from other disciplines, such as Biopsy, Proteinuria, Bone marrow and Renal function.
His study in Survival rate is interdisciplinary in nature, drawing from both Multivariate analysis and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
